Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Selvita S.A.
DescriptionDual Pim-1 (PIM1) and FMS-like tyrosine kinase 3 (FLT3; CD135) inhibitor
Molecular Target Pim-1 (PIM1) ; FMS-like tyrosine kinase 3 (FLT3) (CD135)
Mechanism of ActionFMS-like tyrosine kinase 3 (FLT3) inhibitor; PIM1 inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today